Treatment with tralokinumab improves health-related quality of life in adult patients with moderate to severe atopic dermatitis: results from a Phase 2b, randomised, double-blind, placebo-controlled study

Main Article Content

Jonathan I Silverberg
Nana Kragh
Emma Guttman-Yassky
Andreas Wollenberg

Keywords

Abstract

Abstract not available.

 

Disclosures: Study sponsored by LEO Pharma.

 

Copyright 2018 SKIN